UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology

Cancers, 2023-02, Vol.15 (5), p.1443

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of everolimus and bevacizumab in recurrent ovarian, peritoneal, and fallopian tube cancer

Gynecologic oncology, 2020-01, Vol.156 (1), p.32-37

2020

Link zum Volltext

Verfügbarkeit prüfen

Germline and Somatic Testing in Ovarian Cancer: Shifting Sands of Recommendations

Gynecologic oncology, 2020-03, Vol.156 (3), p.515-516

2020

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

Clinical cancer research, 2005-09, Vol.11 (18), p.6422-6430

2005

Link zum Volltext

Verfügbarkeit prüfen

Germline pathogenic variants identified in women with ovarian tumors

Gynecologic oncology, 2018-12, Vol.151 (3), p.481-488

2018

Link zum Volltext

Verfügbarkeit prüfen

BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer

Gynecologic oncology, 2012-06, Vol.125 (3), p.677-682

2012

Link zum Volltext

Verfügbarkeit prüfen

Use of Metformin in Obese Women With Type I Endometrial Cancer Is Associated With a Reduced Incidence of Cancer Recurrence

International journal of gynecological cancer, 2016-02, Vol.26 (2), p.313-317

2016

Link zum Volltext

Verfügbarkeit prüfen

Using video stimulus for mathematical open inquiry : Problem-posing and investigations

Australian primary mathematics classroom, 2022, Vol.27 (2), p.31-35

2022

Link zum Volltext

Verfügbarkeit prüfen

Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013-2018

Hereditary cancer in clinical practice, 2022-05, Vol.20 (1), p.19-19, Article 19

2022

Link zum Volltext

Verfügbarkeit prüfen

What’s in Between the Lines: Assessing the Readability, Understandability, and Actionability in Breast Cancer Survivorship Print Materials

Journal of cancer education, 2022-10, Vol.37 (5), p.1532-1539

2022

Link zum Volltext

Verfügbarkeit prüfen

High-Dose-Rate Rotte “Y” Applicator Brachytherapy for Definitive Treatment of Medically Inoperable Endometrial Cancer: 10-Year Results

International journal of radiation oncology, biology, physics, 2008-07, Vol.71 (3), p.779-783

2008

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers

Clinical cancer research, 2005-09, Vol.11 (17), p.6300-6310

2005

Link zum Volltext

Verfügbarkeit prüfen

Can Automated Alerts in the Electronic Health Record Encourage Referrals for Genetic Counseling and Testing Among Patients at High Risk for Hereditary Cancer Syndromes?

JCO oncology practice, 2022-07, Vol.18 (7), p.e1219-e1224

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer

International journal of gynecological cancer, 2019-01, Vol.29 (1), p.147-152

2019

Link zum Volltext

Verfügbarkeit prüfen

Challenges in recruiting African-American women for a breast cancer genetics study

Hereditary cancer in clinical practice, 2018-04, Vol.16 (1), p.8-8, Article 8

2018

Link zum Volltext

Verfügbarkeit prüfen

PARP inhibition in epithelial ovarian cancer: high hopes undergo a reality check

Oncology (Williston Park, N.Y.), 2012-02, Vol.26 (2), p.128-136

Zorn, Kristin K

2012

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Inhibiting PARP as a Strategic Target in Cancer

Frontiers in oncology, 2016-04, Vol.6, p.91-91

2016

Link zum Volltext

Verfügbarkeit prüfen

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era

OncoTargets and therapy, 2014-01, Vol.7 (default), p.1409-1413

2014

Link zum Volltext

Verfügbarkeit prüfen

The Prognostic Value of Pretreatment CA 125 in Patients With Advanced Ovarian Carcinoma : A Gynecologic Oncology Group Study

Cancer, 2009-03, Vol.115 (5), p.1028-1035

2009

Link zum Volltext

Verfügbarkeit prüfen

Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease?

Gynecologic oncology, 2010-05, Vol.117 (2), p.308-311

2010

Link zum Volltext

Verfügbarkeit prüfen

Venous Thromboembolism in Obstetrics and Gynecology

Obstetrics and gynecology (New York. 1953), 2007-03, Vol.109 (3), p.761-777

2007

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin salvage for recurrent ovarian cancer: A single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity

Gynecologic oncology, 2014-07, Vol.134 (1), p.68-72

2014

Link zum Volltext

Verfügbarkeit prüfen

Inhibiting PARP as a Strategic Target in Cancer

2016

Link zum Volltext

Verfügbarkeit prüfen

Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer

International journal of gynecological cancer, 2016-05, Vol.26 (4), p.626-631

2016

Link zum Volltext

Verfügbarkeit prüfen

Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma

Gynecologic oncology, 2007-09, Vol.106 (3), p.498-501

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(56)
Humans
(43)
Oncology
(38)
Female
(37)
Middle Aged
(26)
Aged
(25)
Obstetrics & Gynecology
(24)
Adult
(19)
Ovarian Cancer
(15)
Aged, 80 And Over
(13)
Hematology, Oncology And Palliative Medicine
(13)
Ovarian Neoplasms - Drug Therapy
(13)
Neoplasm Staging
(12)
Retrospective Studies
(12)
Obstetrics And Gynecology
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Ovarian Neoplasms - Genetics
(9)
Ovarian Neoplasms - Pathology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology

Phase II study of everolimus and bevacizumab in recurrent ovarian, peritoneal, and fallopian tube cancer

Germline and Somatic Testing in Ovarian Cancer: Shifting Sands of Recommendations

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

Germline pathogenic variants identified in women with ovarian tumors

BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer

Use of Metformin in Obese Women With Type I Endometrial Cancer Is Associated With a Reduced Incidence of Cancer Recurrence

Using video stimulus for mathematical open inquiry : Problem-posing and investigations

Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013-2018

What’s in Between the Lines: Assessing the Readability, Understandability, and Actionability in Breast Cancer Survivorship Print Materials

High-Dose-Rate Rotte “Y” Applicator Brachytherapy for Definitive Treatment of Medically Inoperable Endometrial Cancer: 10-Year Results

Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers

Can Automated Alerts in the Electronic Health Record Encourage Referrals for Genetic Counseling and Testing Among Patients at High Risk for Hereditary Cancer Syndromes?

Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer

Challenges in recruiting African-American women for a breast cancer genetics study

PARP inhibition in epithelial ovarian cancer: high hopes undergo a reality check

Editorial: Inhibiting PARP as a Strategic Target in Cancer

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era

The Prognostic Value of Pretreatment CA 125 in Patients With Advanced Ovarian Carcinoma : A Gynecologic Oncology Group Study

Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease?

Venous Thromboembolism in Obstetrics and Gynecology

Oxaliplatin salvage for recurrent ovarian cancer: A single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity

Inhibiting PARP as a Strategic Target in Cancer

Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer

Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma

Suchergebnisse filtern